期刊文献+

新型复合纤维蛋白胶可注射性磷酸钙人工骨的理学特性 被引量:5

Physics characteristics of a new-type composite of injectable calcium phosphate cement and fibrin glue
下载PDF
导出
摘要 目的:检测纤维蛋白胶复合β-磷酸三钙/磷酸二氢钙复合人工骨材料的物理学性能,评价纤维蛋白胶对β-磷酸三钙/磷酸二氢钙骨水泥性能的影响,以及其作为注射型复合人工骨用于修复骨缺损的可行性。方法:实验于2006-12/2007-06在南方医科大学珠江医院中心实验室和华南理工大学生物材料实验室完成。①材料:β-磷酸三钙由上海瑞邦生物材料有限公司提供,磷酸二氢钙为东泰化工赠,纤维蛋白胶购自广州倍绣生物技术有限公司。②复合材料制备:将β-磷酸三钙/磷酸二氢钙骨水泥按3∶1的比例充分混合后,与纤维蛋白胶按凝固后的体积2∶1体积比混合,制成复合人工骨材料。③观察指标:测定复合材料的凝固时间,抗压强度,抗稀散性能,并用扫描电镜观察其煅烧前后的显微结构特征,以未加纤维蛋白胶的磷酸钙水泥为对照(CPC组)。结果:复合人工骨材料的平均初凝时间长于CPC组(P<0.004),终凝时间在初凝时间后2~4 min;复合材料的抗压强度为(14.72±1.81)MPa。复合材料较CPC组有良好的抗稀散性能,扫描电镜发现,纤维蛋白胶贯穿于磷酸钙水泥晶体间,并将磷酸钙水泥晶体紧密连接。煅烧后复合材料的孔径有增大,空隙率为57.28%,并且微孔之间有空隙互相贯通。结论:该骨水泥复合材料凝固时间符合临床操作的需要;抗压强度达到松质骨强度的要求;煅烧后磷酸钙水泥的空隙率明显提高,有利于材料的降解。 AIM: To study the physics performance of fibrin glue compound β-tricalcium phosphate (β-TCP)/monocalcium phosphate artificial bone material, evaluate the effect of fibrin glue on β-TCP/monocalcium phosphate, and investigate the feasibility of applying it as an injectable artificial bone to repair bone defects. METHODS: From December 2006 to June 2007, the experiment was carried out in the Central Laboratory, Zhujiang Hospital of Southern Medical University and the Biomaterials Laboratory, South China University of Technology.(1)β-TCP was offered by Shanghai Rebone Biomaterials CO., LTD. monocalcium phosphate was offered by Dongtai Chemical Industry Co., Ltd. Fibrin glue was purchased from Guangzhou Bioseal Biotech Co.,Ltd.(2)β-TCP/monocalcium phosphate was full mixed by 3:1, then mixed with fibrin glue at the ratio of 2:1 to prepare the compound artificial bone. (3)The coagulation time, compressive strength, resistance scattered performance of composite material were determined, and the characteristic of its microstructure was observed before and after calcinations by using scanning electron microscope. While those calcium phosphate cement without the fibrin glue was served as control group.RESULTS: The average initial setting time of the compound materials was longer than that of control group (P 〈 0.004), and the final setting time was 2-4 minutes after the initial setting time; the compressive strength of composite materials was (14.72±1.81) MPa. Compared with the control group, composite materials had good performance against scattered, and scanning electron microscope result revealed that the fibrin glue penetrated throughout calcium phosphate crystals, which were connected tightly. After calcination, the porosity of compound materials increased to 57.28%, and the gap between the micropores was mutual linked.CONCLUSION: The bone cement composite material is suitable for the clinical operation in aspects of coagulation time; the compressive strength fits for the can
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第48期9633-9636,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 南方医科大学院长基金资助课题(2006)~~
  • 相关文献

参考文献20

  • 1Daculsi G, Rohanizadeh R, Weiss P, et al. Crystal polymer interaction with new injectable bone substitute; SEM and Hr TEM study. J Biomed Mater Res 2000; 50(1): 1-7. 被引量:1
  • 2Xu HH, Weir MD, Burguera EF, et al. Injectable and macroporous calcium phosphate cement scaffold. Biomaterials 2006;27 (24): 4279-4287. 被引量:1
  • 3Bohner M, Baroud G. Injectability of calcium phosphate pastes. Biomaterials 2005;26(13):1553-1563. 被引量:1
  • 4Burguera EF, Xu HH, Weir MD. Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate. J Biomed Mater Res B Appl Biomater 2006;77(1):126-134. 被引量:1
  • 5del Real RP, Wolke JG, Vallet-Regi M, et al. A new method to produce macropores in calcium phosphate cements. Biomaterials 2002;23(17): 3673-3680. 被引量:1
  • 6von Doernberg MC, von Rechenberg B, Bohner M, et al. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials 2006; 27(30):5186-5198. 被引量:1
  • 7Schips L, Dalpiaz O, Cestari A, et al. Autologous fibrin glue using the Vivostat system for hemostasis in laparoscopic partial nephrectomy. Eur Urol 2006; 50(4):801-805. 被引量:1
  • 8Bohner M, Merkle HP, Landuyt PV, et al. Effect of several additives and their admixtures on the physico-chemical properties of a calcium phosphate cement. J Mater Sci Mater Med 2000; 11(2):111-116. 被引量:1
  • 9Mader JT, Stevens CM, Stevens JH, et al. Treatment of experimental osteomyelitis with a fibrin sealant antibiotic implant.Clin Orthop Relat Res 2002; (403):58-72. 被引量:1
  • 10张力,李奇,唐银丽,吴广森,田京.增强组织工程支架:纤维蛋白胶稳定性的初步研究[J].中国临床康复,2003,7(2):218-219. 被引量:17

二级参考文献8

  • 1[2]Zhang X,Yan XH.Bone tissue engineered entracellar matrix material.Xiandai Kangfu(Modren Rehabil) 2001,6(2):18- 9 被引量:1
  • 2[3]Zhao YB,Fan QY,Zhou Y,et al.Manufacture and clinical aplication of tissue engineering skin.Zhongguo Linchuang Kangfu(Chin J Clin Rehabil) 2002;6(10):1421 被引量:1
  • 3[4]Yang SY,Lei DL,Yang WD,et al.Repair of skull defects of rabbit with alginateZhonggou Linchuang Kangfu(Chin J Clin Rehabil)2002;6(12):1746 被引量:1
  • 4[5]Zhang ZF,Shang QX,Chang YL.Experimental study on aging of cnltared tenoeytes in vitro.Zhonggou Linchuang Kangfu(Chin J Clin Rehabil) 2002;6(22):3376 被引量:1
  • 5[6]Liu DW,Li GH,Liu DM,et al.The application of pelylactic acid in the studies on the engineered growth plate.Zhongguo Linchuang Kangfu(Chin J Clin Rehabil) 2002;6(12):1742 被引量:1
  • 6[7]Sims CD,Butler PE,Cao YL,et al.Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes.Plast Reconstr Surg 1998;101(6):1580- 5 被引量:1
  • 7[8]Homminga GN,Buma P,Koot HWJ,et al.Chondrocyte behavior in fibrin glue.Acta Orthop Scand 1993;64(4):441- 5 被引量:1
  • 8[9]Ting V,Sims CD,Brecht LE,et al.In vitro prefabrication of human cartilage shapes using fibrin glue and human chondrocytes.Ann Plast Surg 1998;40(4): 413- 20 被引量:1

共引文献16

同被引文献61

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部